"Personalized Genetics" Testing Shut Down by FDA The November issue of San Francisco Medicine contains a "perspective" piece titled "Commercialized Genomics: Caveat Emptor" by SFMS staff member Steve Heilig. November 26, 2013 San Francisco Medicine 23andMe, Commercialized Genomics, San Francisco Medicine, SFM 0 0 Comment Read More »
